Skip to Main Content

Advertisement

Skip Nav Destination

Generation of Immunity to the HER-2/neu Oncogenic Protein in Patients with Breast and Ovarian Cancer Using a Peptide-based Vaccine1

Clin Cancer Res (1999) 5 (6): 1289–1297.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal